Header Image - Gluten Light
Gallery

Magazine

Pasta madre e prodotti per persone geneticamente predisposte per la celiachia

by luciano

I batteri lattici presenti nella madre hanno dimostrato di avere notevoli capacità di idrolizzate le proteine del glutine; alcune selezioni di batteri lattici utilizzati con specifiche temperature, tempi e concentrazioni possono anche idrolizzare i peptidi più resistenti alla digestione gastro-intestinale. I prodotti da forno realizzati con pasta acida possono, pertanto, essere considerati una ottima opportunità e una valida scelta per le persone geneticamente predisposte per la celiachia.

Estratto dallo studio “Gluten-Free Products for Celiac Susceptible People”:

A – “ omissis…… The 33-mer peptide from α2-gliadin (amino acid sequence positions 56–88, LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF) contains three overlapping T-cell epitopes (3 × PQPQLPYPQ, 2 × PYPQPQLPY and PFPQPQLPY) for CD sensitive individuals. The human gastrointestinal enzymes pepsin, trypsin, and chymotrypsin were unable to hydrolyze the 33-mer peptide due to their inability to cleave before or after proline or glutamine, leaving the epitopes intact. Comparatively, large CD immunogenic peptides (≥9 amino acid residues) reach the small intestine (11) after crossing through the epithelial barrier and initiate immunogenic cascade in the laminapropria.

B – “omissis …Wheat flours modified to eliminate or reduce the immune toxicity of gluten have been used to prepare pasta and baked products. The large peptides of gluten need to be modified/converted into peptides of <9 amino acid residues to minimize the CD-induced immunoreactivity. This has been achieved through numerous approaches, including exogenous enzyme treatment, use of sourdough/lactic acid bacteria, use of genetically modified wheat, etc.”

C – “ omissis…The sourdough was prepared by fermenting flour with naturally occurring lactic acid bacteria (LAB) and yeasts. In the mature sourdoughs, the lactic acid bacteria were higher in number (> 10cfu/g) than the number of yeasts. Type I sourdough has a final pH of 4.0 at room temperature (20–30C) and is manufactured by continuous daily refreshments with the aim to maintain the microorganisms in an active state. It takes 2–5 (>30C) days of fermentation for developing type II sourdough as an acidifier with a pH that is <3.5 after 24 h of fermentation (131). The microorganisms were used in the late stationary phase of growth and exhibited restricted metabolic activity. The type III sourdough, as an acidifier supplement and aroma carrier in bread making, is a dried powder used for fermentation by certain starter cultures. A few reports are available about the use of sourdough for the preparation of gluten-free bread (84, 85). In one study it was reported that food processing by selected sourdough lactobacilli and fungal proteases may be considered an efficient approach for eliminating gluten toxicity, reducing the gluten level below 12 ppm (119). Further, sourdough fermentation, usually with a mixture of lactic acid bacteria (LAB) and yeasts, is traditionally used to produce leavened bread, especially from rye flour. Lactobacillus sp. are predominant among lactic acid bacteria (LAB) and they produce numerous mixed proteolytic enzymes, including metalloendopeptidases, such as PepO and PepF; aminopeptidases, such as PepN and PepC; dipeptidases, such as PepD; and dipeptidyl and tripeptidylpeptidases, such as the proline-specific Xaa-Pro dipeptidyl-peptidase (PepX) (132). The combination of wheat germination and sourdough fermentation with Lactobacillus brevis L62 extensively hydrolyzed wheat prolamin down to <5% of the initial content (133). A cell-free extract of two LABs, L. plantarum and Pediococcus pentosaceus, had a higher gliadin-degrading capacity (83%) in doughs than the corresponding cell suspension (70%), and complete gliadin degradation without using live LAB may be optimized (134). High molecular weight polymers, namely exopolysaccharides, are produced by lactic acid bacteria in presence of sucrose that mimics physiochemical properties of commercial hydrocolloids or gums, such as the ability to form a network and bind water. It counteracts the negative effects of excessive sourdough acidification and enhances loaf volume, shelf-life, the staling rate, and textural properties of products (129).”

Approfondimento
Gluten-Free Products for Celiac Susceptible People. Sweta Rai, Amarjeet Kaur and C. S. Chopra. Front. Nutriens 17 december 2018.

ATI (inibitori dell’amilasi/tripsina) Parte I

by luciano

Riassunto
Gli inibitori dell’amilasi/tripsina (ATI) sono tra i fattori scatenanti della sensibilità al glutine non celiaca (NCGS). Le Ati (le ati ritenute predominanti 0,19 + 0,53, 0,28, CM2, CM3 e CM16) di otto cultivar ciascuna di grano tenero, grano duro, farro spelta, farro dicocco e monococco, coltivati ​​nelle stesse condizioni ambientali, sono state quantificate mediante spettrometria di massa liquida-tandem mirata liquida (LC) -MS / MS) e saggi di diluizione isotopica stabile (SIDA) utilizzando peptidi marker specifici come standard interni. I risultati sono stati confrontati con un’analisi LC-MS / MS non mirata senza etichetta, in cui le concentrazioni di proteine ​​sono state determinate mediante quantificazione assoluta basata sull’intensità (iBAQ). Entrambi gli approcci hanno prodotto risultati simili. Il farro spelta e il farro dicocco avevano un contenuto di ATI più elevato rispetto al grano tenero, con grano duro in mezzo. Solo tre delle otto cultivar Einkorn contenevano ATI in concentrazioni molto basse. La distribuzione dei tipi di ATI era caratteristica per le specie di grano esaploide, tetraploide e diploide ed utilizzabile come impronta digitale specifica per specie. I risultati indicano che il grano monococco, avendo un contenuto di ATI totale molto basso, presenta una migliore tollerabilità per i pazienti con NCGS. (Targeted LC-MS/MS Reveals Similar Contents of α-Amylase/Trypsin-Inhibitors as Putative Triggers of Nonceliac Gluten Sensitivity in All Wheat Species except Einkorn). Article in Journal of Agricultural and Food Chemistry 66(46) · October 2018. Sabrina Geisslitz, Christina Ludwing, Katharina Scherf (Technische Universität München Munich, Bayern, Germany).

Reintroduzione del glutine, dopo un certo periodo, in una dieta priva di glutine per soggetti sensibili al glutine non celiaci.

by luciano

“Una volta ragionevolmente raggiunta la diagnosi di NCGS, la gestione e il follow-up dei pazienti sono completamente oscuri. Un approccio logico consiste nell’intraprendere un regime dietetico senza glutine per un periodo limitato (ad esempio, sei mesi), seguito dalla graduale reintroduzione del glutine. Durante la dieta priva di glutine, dovrebbe essere evitata l’ingestione del peptide prolaminico (gliadina), derivato da grano, segale, orzo, avena, bulgur e ibridi di questi cereali. Riso, mais e patate sono stati i tipici sostituti, ma oggigiorno si possono usare altri cereali e pseudocereali diversi come amaranto, grano saraceno, manioca, fonio, teff, miglio, quinoa e sorgo. Dopo un po ‘di tempo con una dieta priva di glutine, la reintroduzione del glutine può iniziare con cereali a basso contenuto di glutine (ad es. Avena). Inoltre, è possibile utilizzare il farro einkorn (Triticum monococcum), che non presenta tossicità diretta in vitro o ex vivo e basso contenuto di glutine (7%)[41]”. (Non-celiac gluten sensitivity: Time for sifting the grain. Luca Elli, Leda Roncoroni, and Maria Teresa Bardella. Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved).

Prevenzione della celiachia: dieta con grano con ridotta quantità di epitopi stimolatori delle principali T-cellule.

by luciano

La ricerca scientifica ha più volte sostenuto ed incoraggiato l’utilizzazione di grani a bassa tossicità nella prevenzione della celiachia; Nella ricerca che ora presentiamo sono stati studiati alcuni grani evidenziando il loro profilo riguardo sia la presenza dei peptidi resistenti alla digestione gastro-intestinale sia, tra questi, quelli contenenti la frazione “tossica” (Summary of the GD-resistant peptides identified at the end of the duodenal phase and counting of the peptides encrypting full length epitopes relevant for celiac disease (CD) and wheat allergy  (table 3) “….omissis Even if none of them can be considered safe for CD patients, grain with reduced amount of major T-cell stimulatory epitopes may help in the prevention of CD, since previous studies demonstrated that the amount and duration to gluten exposure are strictly linked to the initiation of this pathology.” (A Comprehensive Peptidomic Approach to Characterize the Protein Profile of Selected Durum Wheat Genotypes: Implication for Coeliac Disease and Wheat Allergy. Rosa Pilolli , Agata Gadaleta, Luigia Di Stasio , Antonella Lamonaca, Elisabetta De Angelis , Domenica Nigro , Maria De Angelis , Gianfranco Mamone and Linda Monac. Published: 1 October 2019).

Abstract
The wheat varietal selection undertaken by breeders in recent decades has been tailored mainly to improve technological and productivity-related traits; however, the latter has resulted in a considerable impoverishment of the genetic diversity of wheat-based products available on the market. This pitfall has encouraged researchers to revalue the natural diversity of cultivated and non-cultivated wheat genotypes in light of their different toxic/immunogenic potential for celiac disease and wheat-allergic patients. In the present investigation, an advanced proteomic approach was designed for the global characterization of the protein profile of selected tetraploid wheat genotypes (Triticum turgidum). The approach combined proteins/peptides sequence information retrieved by specific enzymatic digestions (single and dual proteolytic enzymes) with protein digestibility information disclosed by means of in-vitro simulated human gastroduodenal digestion experiments. In both cases, the peptide pools were characterized by discovery analysis with liquid chromatography high-resolution tandem mass spectrometry, and specific amino acid sequences were identified via commercial software. The peptide list was screened for in silico toxicity/immunogenicity risk assessment, with the aid of various open-source bioinformatics tools for epitopes matching. Given the global information provided by the designed proteomic approach, the in silico risk assessment not only tackled toxicity implication for celiac disease patients, but also scouted for immunogenic sequences relevant for wheat allergic patients, achieving a comprehensive characterization of the protein profile of the selected genotypes. These latter were assessed to encrypt a variable number of toxic/immunogenic epitopes for celiac disease and wheat allergy, and as such they could represent convenient bases for breeding practices and for the development of new detoxification strategies.